GL Pharm Tech지엘팜텍
204840 · KOSDAQ · ₩204840 · 지엘팜텍
₩3,580 ₩0 (0.00%)End-of-day · Oct 27, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 40.3% | 40.6% | 39.6% | 33.5% | 29.2% | 30.3% |
| Operating margin | 0.6% | 0.8% | −6.8% | −12.4% | −19.5% | −21.7% |
| Net margin | 0.1% | 0.0% | −9.0% | −14.4% | −4.7% | −30.1% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +8.3% | +35.4% | +0.1% | +55.6% | +34.6% | — |
| Operating income growth | −16.5% | +115.2% | +45.2% | +0.8% | −20.8% | — |
| Net income growth | +196.0% | +100.5% | +37.6% | −374.4% | +78.8% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | 0.2% | 0.1% | −14.6% | −26.4% | −4.8% | −22.2% |
| Return on assets | 0.1% | 0.0% | −5.7% | −9.3% | −2.2% | −11.7% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 146.4% | 145.1% | 115.8% | 224.6% | 153.9% | 82.5% |
| Net debt to equity | 87.0% | 77.2% | 51.2% | 109.8% | 56.8% | 8.5% |
| Current ratio | 98.0% | 101.0% | 136.7% | 134.9% | 123.6% | 272.7% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: GL Pharm Tech / 지엘팜텍 / 204840 / KRX:204840
Source: KRX statistical information